(Q38125030)

29 August 2017

title

Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery (English)

1 reference

29 August 2017

1 reference

John R Benson

1

1 reference

29 August 2017

Gordon C Wishart

series ordinal

2

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Lancet Oncology Commission

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

e348-57

1 reference

Mammographic screening: a key factor in the control of breast cancer.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Image-detected breast cancer: state of the art diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

The benefits and harms of breast cancer screening: an independent review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

The clinical significance of pre-invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Genesis and source of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Is screening for breast cancer with mammography justifiable?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Gene expression profiles of human breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Ductal Carcinoma in Situ of the Breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Trends in the treatment of ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

An adequate margin of excision in ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Predictors of reexcision findings and recurrence after breast conservation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

The influence of margin width on local control of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Network meta-analysis of margin threshold for women with ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Oncological advantages of oncoplastic breast-conserving surgery in treatment of early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Prospective study of wide excision alone for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Genetic pathways in the evolution of breast ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Post-operative radiotherapy for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970135-9

7 January 2021

10.1016/S1470-2045(13)70135-9

Identifiers

DOI

1 reference

29 August 2017

1 reference